Mitchell, H.
Cairnduff, V.
O’Hare, S.
Simpson, L.
White, R.
Gavin, AT
Article History
Received: 14 June 2023
Accepted: 27 October 2023
First Online: 31 October 2023
Declarations
:
: This study was conducted on anonymised data in accordance with Northern Ireland Cancer Registry (NICR) Confidentiality and Data Protection Policies. The NICR has ethical approval from the Office for Research Ethics Committees of Northern Ireland (ORECNI) (Ref: 20/NI/0132 Integrated Research Application System (IRAS) project ID: 288121), for the collection and use of routinely collected data relating to cancer patients. The ethical approval granted by ORECNI to the NICR covers the work conduced in this study and as such, specific ethical approval and informed consent from the data subjects were not required for this study. All methods were subject to scientific critique and all data processing and analysis was conducted in accordance with the ORECNI conditions for ethical approval to use this data. Office for Research Ethics Committees of Northern Ireland (ORECNI) waived then need for study specific ethical approval and informed consent.
: Not applicable.
: The authors declare no competing interests.